<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02482025</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 14-059</org_study_id>
    <nct_id>NCT02482025</nct_id>
  </id_info>
  <brief_title>The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial</brief_title>
  <acronym>SMMRT</acronym>
  <official_title>The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Medication discrepancies, defined as unintentional differences found between patients'&#xD;
      medical records and patients' reports of the medication they are taking, occur frequently&#xD;
      after hospital discharge, predisposing to adverse drug events (ADEs), emergency department&#xD;
      visits and readmissions. Resolving medication discrepancies - medication reconciliation - is&#xD;
      mandated at every care transition, but little is known about intervention strategies to&#xD;
      improve medication reconciliation in the post-discharge period, when patients may lack prompt&#xD;
      access to primary care and are at high risk for ADEs. To address this gap, the investigators&#xD;
      developed and pilot tested the Secure Messaging for Medication Reconciliation Tool (SMMRT),&#xD;
      with a pharmacist communicating with Veterans to review medications and reconcile&#xD;
      discrepancies after hospital discharge via Secure Messaging (SM), within My HealtheVet (MHV),&#xD;
      VA's patient portal. The objectives of The SMMRT Trial are therefore&#xD;
&#xD;
      To optimize the end-users' experience with SMMRT through usability testing and refinement of&#xD;
      the tool; To conduct a randomized controlled trial (RCT) of usual care vs. usual care plus&#xD;
      MHV Training vs. usual care plus MHV Training plus SMMRT to reduce hospital utilization; To&#xD;
      evaluate how Veterans and staff perceived the impact of SMMRT on routine clinical practices&#xD;
      and, specifically, on Veterans' interactions with their primary care providers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Procedure of Work Done at Richard L. Roudebush VAMC in Indianapolis&#xD;
&#xD;
      Aim 1 of SMMRT will be conducted at the Human-Computer Interaction &amp; Simulation Laboratory&#xD;
      within the HSR&amp;D Center for Health Information and Communication at the Richard L. Roudebush&#xD;
      VAMC in Indianapolis, IN. The work in Indianapolis will include a formal usability test of&#xD;
      SMMRT to access and improve usability for pharmacists, nurses, and patients. Ten VA&#xD;
      pharmacists, 10 VA nurses, and 10 VA patients will participate in the usability tests in&#xD;
      Indianapolis. They will assess how well the SMMRT interface supports their respective&#xD;
      medication reconciliation tasks. Pharmacists who work for the Roudebush VAMC and have some&#xD;
      responsibility for medication reconciliation in their normal work will be eligible to&#xD;
      participate in the study. Roudebush VAMC nurses who work as part of a Patient Aligned Care&#xD;
      Team (PACT) will be eligible. Eligible patients must be taking at least 5 medications and&#xD;
      must have been discharged from the Roudebush VAMC within the last 30 days. Veterans will be&#xD;
      excluded if they are cognitively impaired, based on the Callahan screener. Patients will be&#xD;
      recruited regardless of prior MHV use. No patients will have previous experience with SMMRT,&#xD;
      as it is a new feature in MHV. Usability testing sessions will be about 30 minutes and will&#xD;
      include audio and video recordings of the computer screen movements and the participant's&#xD;
      face. A standardized script is read to the participants to instruct them to do certain tasks&#xD;
      that will evaluate specific usability issues in the SMMRT. The participants enter reconciled&#xD;
      medications into the SMMRT and the completed work is sent to the research team for analysis.&#xD;
&#xD;
      Although the investigators intend to complete all data collection procedures for Aim 1 at the&#xD;
      Indianapolis VA, the investigators did note in the submitted grant proposal (Section 4.g.1)&#xD;
      that the investigators would recruit (VA) Boston pharmacists for Aim 1 data collection in the&#xD;
      unlikely event that the investigators cannot recruit sufficient numbers from Indianapolis. If&#xD;
      that unlikely contingency arises (i.e., the investigators determine that there is a need to&#xD;
      recruit pharmacists from VA Boston), the investigators will submit an amendment to the VA&#xD;
      Boston IRB with appropriate consent and authorization forms at that time.&#xD;
&#xD;
      Study Procedure of Work at VABHS. The Study has received approval for a Project Modification.&#xD;
&#xD;
      The essential scientific changes of the proposed modification are (1) switching from a&#xD;
      three-arm to a two-arm RCT; (2) changing the main outcome measure from hospital utilization&#xD;
      to medication discrepancies; and (3) reducing the sample size from 1400 to 240 subject. The&#xD;
      second specific aim of the Project will become the following:&#xD;
&#xD;
      Aim 2. To conduct a two-arm RCT to evaluate the effect of SMMRT. This trial will compare&#xD;
      Usual Care (UC) with UC plus the bundled MHV/SMMRT Intervention among Veterans discharged&#xD;
      from the VA Boston Community Living Center (CLC) and from the VA Boston acute inpatient&#xD;
      setting of West Roxbury. The primary outcome measure will be medication discrepancies&#xD;
      detected 30 days after discharge. Secondary outcome measures will be 30-day hospital&#xD;
      utilization (combined readmissions plus emergency department use) and Veterans' self-efficacy&#xD;
      in medication use. The primary hypothesis is that SMMRT will result in a reduction in 30-day&#xD;
      medication discrepancies as compared with UC.&#xD;
&#xD;
      The third specific aim of the Project remains unchanged:&#xD;
&#xD;
      Aim 3. To evaluate the SMMRT intervention for potential future implementation. In&#xD;
      anticipation of future implementation, we will use qualitative methods to identify features&#xD;
      of the intervention that are most and least effective, as well as elements that are most and&#xD;
      least likely to be accepted into clinical practice.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 16, 2018</start_date>
  <completion_date type="Actual">June 10, 2020</completion_date>
  <primary_completion_date type="Actual">October 22, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Medication Discrepancies</measure>
    <time_frame>30 days after hospitalization</time_frame>
    <description>Medication discrepancies (discrepancies between what the patient is taking and what is in the medical record) identified 30 days after hospitalization via telephone interview and review of medical record</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital Utilization</measure>
    <time_frame>30 days</time_frame>
    <description>Hospital utilization, defined as re-admissions or emergency department utilization, within 30 days of hospital discharge.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">240</enrollment>
  <condition>Drug-Related Side Effects and Adverse Reactions</condition>
  <condition>Adverse Drug Events</condition>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care delivered at VA Boston</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SMMRT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Receives Usual Care PLUS SMMRT Intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SMMRT</intervention_name>
    <description>Includes My HealtheVet registration and enrollment</description>
    <arm_group_label>SMMRT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Veterans age 18 years or older&#xD;
&#xD;
          -  Having a VA primary care provider (PCP) at any VA facility in VISN-1&#xD;
&#xD;
          -  Planned discharge home (as opposed to another facility)&#xD;
&#xD;
          -  Computer and internet access&#xD;
&#xD;
          -  Anticipated to be discharged with at least 5 medications.&#xD;
&#xD;
               -  Having a VA PCP will be defined as having seen the provider within the past two&#xD;
                  years&#xD;
&#xD;
               -  Planned discharge home will be ascertained from the Veteran's nurse;&#xD;
                  approximately 75% of VA Boston discharges are to home&#xD;
&#xD;
               -  The nurse will also provide number of anticipated discharge medications&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cognitive impairment (as determined by the Callahan screener)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amy M Linsky, MD MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>June 23, 2015</study_first_submitted>
  <study_first_submitted_qc>June 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2015</study_first_posted>
  <results_first_submitted>October 27, 2020</results_first_submitted>
  <results_first_submitted_qc>October 27, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 19, 2020</results_first_posted>
  <last_update_submitted>October 27, 2020</last_update_submitted>
  <last_update_submitted_qc>October 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Medications</keyword>
  <keyword>Hospitalization</keyword>
  <keyword>Electronic medical records</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Drug-Related Side Effects and Adverse Reactions</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Not sharing individual patient data.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 31, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/25/NCT02482025/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Usual Care</title>
          <description>Usual care delivered at VA Boston</description>
        </group>
        <group group_id="P2">
          <title>SMMRT</title>
          <description>Receives Usual Care PLUS SMMRT Intervention&#xD;
SMMRT: Includes My HealtheVet registration and enrollment</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="122"/>
                <participants group_id="P2" count="118"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="122"/>
                <participants group_id="P2" count="118"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Comparable.</population>
      <group_list>
        <group group_id="B1">
          <title>Usual Care</title>
          <description>Usual care delivered at VA Boston</description>
        </group>
        <group group_id="B2">
          <title>SMMRT</title>
          <description>Receives Usual Care PLUS SMMRT Intervention&#xD;
SMMRT: Includes My HealtheVet registration and enrollment</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="122"/>
            <count group_id="B2" value="118"/>
            <count group_id="B3" value="240"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.1" spread="11.8"/>
                    <measurement group_id="B2" value="63.4" spread="11.7"/>
                    <measurement group_id="B3" value="64.9" spread="11.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="112"/>
                    <measurement group_id="B2" value="110"/>
                    <measurement group_id="B3" value="222"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Race</title>
              <category_list>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="104"/>
                    <measurement group_id="B2" value="100"/>
                    <measurement group_id="B3" value="204"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Non-White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>MyHealtheVet: Yes, No</title>
          <description>Was the Veteran already registered in My HealtheVet at the time of study enrollment? (Yes, No)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>My HealtheVet - Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="107"/>
                    <measurement group_id="B2" value="105"/>
                    <measurement group_id="B3" value="212"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>My HealtheVet - No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Medication Discrepancies</title>
        <description>Medication discrepancies (discrepancies between what the patient is taking and what is in the medical record) identified 30 days after hospitalization via telephone interview and review of medical record</description>
        <time_frame>30 days after hospitalization</time_frame>
        <population>Intention to treat.</population>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Usual care delivered at VA Boston</description>
          </group>
          <group group_id="O2">
            <title>SMMRT</title>
            <description>Receives Usual Care PLUS SMMRT Intervention&#xD;
SMMRT: Includes My HealtheVet registration and enrollment</description>
          </group>
        </group_list>
        <measure>
          <title>Medication Discrepancies</title>
          <description>Medication discrepancies (discrepancies between what the patient is taking and what is in the medical record) identified 30 days after hospitalization via telephone interview and review of medical record</description>
          <population>Intention to treat.</population>
          <units>Medication Discrepancies</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="122"/>
                <count group_id="O2" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.4" spread="4.6"/>
                    <measurement group_id="O2" value="4.4" spread="3.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Utilization</title>
        <description>Hospital utilization, defined as re-admissions or emergency department utilization, within 30 days of hospital discharge.</description>
        <time_frame>30 days</time_frame>
        <population>Intention to Treat.</population>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Usual care delivered at VA Boston</description>
          </group>
          <group group_id="O2">
            <title>SMMRT</title>
            <description>Receives Usual Care PLUS SMMRT Intervention&#xD;
SMMRT: Includes My HealtheVet registration and enrollment</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Utilization</title>
          <description>Hospital utilization, defined as re-admissions or emergency department utilization, within 30 days of hospital discharge.</description>
          <population>Intention to Treat.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="122"/>
                <count group_id="O2" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30-day follow-up</time_frame>
      <desc>30-day follow-up telephone calls</desc>
      <group_list>
        <group group_id="E1">
          <title>Usual Care</title>
          <description>Usual care delivered at VA Boston</description>
        </group>
        <group group_id="E2">
          <title>SMMRT</title>
          <description>Receives Usual Care PLUS SMMRT Intervention&#xD;
SMMRT: Includes My HealtheVet registration and enrollment</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="122"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="118"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="122"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="118"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="122"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="118"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Steven R. Simon, MD</name_or_title>
      <organization>VA Greater Los Angeles Healthcare System</organization>
      <phone>310.268.3132</phone>
      <email>steven.simon2@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

